NZ210816A - Dihydropyridazinones and pharmaceutical compositions - Google Patents

Dihydropyridazinones and pharmaceutical compositions

Info

Publication number
NZ210816A
NZ210816A NZ210816A NZ21081685A NZ210816A NZ 210816 A NZ210816 A NZ 210816A NZ 210816 A NZ210816 A NZ 210816A NZ 21081685 A NZ21081685 A NZ 21081685A NZ 210816 A NZ210816 A NZ 210816A
Authority
NZ
New Zealand
Prior art keywords
compound
formula
methyl
pyridazinone
dihydro
Prior art date
Application number
NZ210816A
Other languages
English (en)
Inventor
R A Slater
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of NZ210816A publication Critical patent/NZ210816A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/22—Nitrogen and oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/28—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to cyano groups, e.g. cyanoguanidines, dicyandiamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Hydrogenated Pyridines (AREA)
NZ210816A 1984-01-13 1985-01-11 Dihydropyridazinones and pharmaceutical compositions NZ210816A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848400863A GB8400863D0 (en) 1984-01-13 1984-01-13 Chemical compounds

Publications (1)

Publication Number Publication Date
NZ210816A true NZ210816A (en) 1987-06-30

Family

ID=10554924

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ210816A NZ210816A (en) 1984-01-13 1985-01-11 Dihydropyridazinones and pharmaceutical compositions

Country Status (31)

Country Link
US (1) US4654342A (forum.php)
EP (1) EP0150937B1 (forum.php)
JP (3) JPS60158181A (forum.php)
KR (1) KR920006781B1 (forum.php)
CN (1) CN85101722A (forum.php)
AT (1) ATE37179T1 (forum.php)
AU (1) AU572252B2 (forum.php)
CA (2) CA1251209A (forum.php)
CS (1) CS248731B2 (forum.php)
DD (1) DD231350A5 (forum.php)
DE (1) DE3564941D1 (forum.php)
DK (1) DK162519C (forum.php)
ES (3) ES8607949A1 (forum.php)
FI (1) FI850140A7 (forum.php)
GB (1) GB8400863D0 (forum.php)
GR (1) GR850068B (forum.php)
HU (1) HU193591B (forum.php)
IE (1) IE57969B1 (forum.php)
IL (1) IL74031A (forum.php)
JO (1) JO1351B1 (forum.php)
MY (1) MY100124A (forum.php)
NO (1) NO850129L (forum.php)
NZ (1) NZ210816A (forum.php)
PH (1) PH22136A (forum.php)
PL (1) PL147123B1 (forum.php)
PT (1) PT79819B (forum.php)
RO (1) RO92607A (forum.php)
SU (1) SU1396963A3 (forum.php)
WO (1) WO1985003076A1 (forum.php)
ZA (1) ZA85251B (forum.php)
ZW (1) ZW385A1 (forum.php)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1251448A (en) * 1985-03-27 1989-03-21 William J. Coates Pyridazinone derivatives
US4946842A (en) * 1985-07-05 1990-08-07 Smith Kline & French Laboratories Limited Novel guanidino pyridazinones as cardiac stimulants
GB8603780D0 (en) * 1986-02-15 1986-03-19 Smith Kline French Lab Chemical compounds
GB8722776D0 (en) * 1987-09-28 1987-11-04 Smith Kline French Lab Chemical compounds
US5011837A (en) * 1988-08-09 1991-04-30 E. R. Squibb & Sons, Inc. Aryl cyanoguanidines: potassium channel activators and method of making same
NZ229828A (en) * 1988-08-09 1992-03-26 Squibb & Sons Inc Aryl cyanoguanidine derivatives and pharmaceutical compositions
AU2002254124A1 (en) 2001-02-27 2002-09-12 Mitokor Aryl-n-cyanoguanidines and methods related thereto
HUP0401747A3 (en) * 2001-11-05 2005-06-28 Merck Patent Gmbh Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
DE102004011512B4 (de) 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmazeutische Zubereitung enthaltend Pimobendan
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (en) * 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US8067433B2 (en) 2005-11-09 2011-11-29 Zalicus Inc. Methods, compositions, and kits for the treatment of ophthalmic disorders
AU2006310997B2 (en) * 2005-11-14 2013-01-10 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors or calcium sensitizers for the treatment of asymptomatic (occult) heart failure
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CN103601792B (zh) 2007-06-04 2016-06-29 协同医药品公司 有效用于胃肠功能紊乱、炎症、癌症和其他疾病治疗的鸟苷酸环化酶激动剂
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
EP2702986A1 (en) 2008-11-25 2014-03-05 Boehringer Ingelheim Vetmedica GmbH Phosphodiesterase type III (PDE III) inhibitors or CA2+-sensitizing agents for the treatment of hypertrophic cardiomyopathy
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EP2681236B1 (en) 2011-03-01 2018-01-03 Synergy Pharmaceuticals Inc. Process of preparing guanylate cyclase c agonists
US20150119399A1 (en) 2012-01-10 2015-04-30 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
EP3167876B1 (en) 2012-03-15 2021-09-08 Boehringer Ingelheim Vetmedica GmbH Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
CA2902348C (en) 2013-02-25 2021-11-30 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
RS65632B1 (sr) 2013-06-05 2024-07-31 Bausch Health Ireland Ltd Ultra-prečišćeni agonisti guanilat-ciklaze c, postupak njihove pripreme i upotrebe
CN105377235A (zh) 2013-07-19 2016-03-02 勃林格殷格翰动物保健有限公司 含有防腐的醚化的环糊精衍生物的液体水性药物组合物
KR20220147691A (ko) 2013-08-09 2022-11-03 알데릭스, 인코포레이티드 인산염 수송을 억제하기 위한 화합물 및 방법
ES2593210T3 (es) 2013-12-04 2016-12-07 Boehringer Ingelheim Vetmedica Gmbh Composiciones farmacéuticas mejoradas de pimobendán
CN104987310A (zh) * 2015-06-03 2015-10-21 青岛农业大学 左西孟旦的合成工艺
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
CN110117257B (zh) * 2018-02-05 2022-12-06 安徽省新星药物开发有限责任公司 一种含胍基的p2y12受体拮抗剂、制备方法及其用途
CN114340631A (zh) 2019-05-21 2022-04-12 阿德利克斯股份有限公司 用于降低患者的血清磷酸盐的组合

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3822260A (en) * 1970-10-09 1974-07-02 American Cyanamid Co 6-(cyanophenyl)-4,5-dihydro-3(2h)-pyridazinones
BE791539A (fr) * 1971-11-19 1973-05-17 Basf Ag Dihydropyridazones, leur preparation et leurs utilisations therapeutiques
EP0030835B1 (en) * 1979-12-05 1983-05-11 Morishita Pharmaceutical Co. Ltd. Derivatives of 2-substituted-6-phenyl-3(2h)pyridazinone, their production and pharmaceutical compositions containing them
FI72718C (fi) * 1981-03-04 1987-07-10 Ciba Geigy Ag Foerfarande foer framstaellning av terapeutiskt verkande, substituerade 6-(4-morfolino-fenyl)-4,5-dihydro- 3(2h)-pyridazinoner och deras syraadditionssalter.
JPS58113180A (ja) * 1981-12-28 1983-07-05 Mitsui Toatsu Chem Inc ピリダジノン誘導体
JPS58140076A (ja) * 1982-02-09 1983-08-19 Mitsubishi Chem Ind Ltd ピリダジノン誘導体又はその塩類
DE3204375C2 (de) * 1982-02-09 1983-12-01 J. Rettenmaier & Söhne GmbH + Co, 7091 Holzmühle Verfahren zur Herabsetzung der Saugfähigkeit von Holz
DE3302021A1 (de) * 1983-01-22 1984-07-26 Basf Ag, 6700 Ludwigshafen 6-aryl-4,5-dihydro-3(2h)-pyridazinone, ihre herstellung und verwendung
US4946842A (en) * 1985-07-05 1990-08-07 Smith Kline & French Laboratories Limited Novel guanidino pyridazinones as cardiac stimulants

Also Published As

Publication number Publication date
PT79819A (en) 1985-02-01
DK9185A (da) 1985-07-14
DK162519C (da) 1992-03-30
HU193591B (en) 1987-11-30
HUT37128A (en) 1985-11-28
KR920006781B1 (ko) 1992-08-17
EP0150937B1 (en) 1988-09-14
DD231350A5 (de) 1985-12-24
ATE37179T1 (de) 1988-09-15
AU572252B2 (en) 1988-05-05
IL74031A0 (en) 1985-04-30
GR850068B (forum.php) 1985-05-03
JPS63313775A (ja) 1988-12-21
JPS63313776A (ja) 1988-12-21
ES8607949A1 (es) 1986-06-01
RO92607A (ro) 1987-11-30
ES8706645A1 (es) 1987-07-01
FI850140L (fi) 1985-07-14
US4654342A (en) 1987-03-31
DK162519B (da) 1991-11-11
DE3564941D1 (en) 1988-10-20
WO1985003076A1 (en) 1985-07-18
MY100124A (en) 1989-12-18
PL251516A1 (en) 1985-12-17
ES8703846A1 (es) 1987-03-01
ZA85251B (en) 1986-08-27
FI850140A7 (fi) 1985-07-14
EP0150937A2 (en) 1985-08-07
AU3761185A (en) 1985-07-18
JO1351B1 (en) 1986-11-30
EP0150937A3 (en) 1985-08-21
DK9185D0 (da) 1985-01-08
KR850005417A (ko) 1985-08-26
JPS60158181A (ja) 1985-08-19
GB8400863D0 (en) 1984-02-15
CA1251209A (en) 1989-03-14
CN85101722A (zh) 1987-01-31
SU1396963A3 (ru) 1988-05-15
IE850069L (en) 1985-07-13
IL74031A (en) 1988-07-31
ES549629A0 (es) 1987-03-01
PT79819B (en) 1987-01-07
CA1260471A (en) 1989-09-26
IE57969B1 (en) 1993-06-02
PL147123B1 (en) 1989-04-29
ES554965A0 (es) 1987-07-01
CA1260471C (forum.php) 1989-09-26
ZW385A1 (en) 1985-08-07
FI850140A0 (fi) 1985-01-11
NO850129L (no) 1985-07-15
ES539446A0 (es) 1986-06-01
PH22136A (en) 1988-06-01
CS248731B2 (en) 1987-02-12

Similar Documents

Publication Publication Date Title
NZ210816A (en) Dihydropyridazinones and pharmaceutical compositions
US5075310A (en) Pyrimidone derivatives as bronchodilators
EP0371731B1 (en) Quinazolinone derivatives
US3995039A (en) Pyrazolo [1,5-a] [1,3,5] triazines
DE69030206T2 (de) Pyrazolopyridinverbindungen und Verfahren zu ihrer Herstellung
EP0208518B1 (en) 6-phenyl-pyridazinyl compounds
EP0201988B1 (en) Dihydropyridazinone derivatives
US4766123A (en) Methylamidine compounds
EP0199465B1 (en) Cyanoalkanimidamido compounds
SU1342416A3 (ru) Способ получени производных пиридазинона или их водорастворимых солей с фармацевтически приемлемой кислотой
EP0134096B1 (en) Aminopyrimidinone derivatives as histamine h2-antagonists
EP0107914A1 (en) Aminopyrimidinone derivatives useful as histamine H1-antagonists
US4962110A (en) Pyridazinone derivatives
US4683228A (en) Guanidinopyrazolylamides, guanidimoimidazolylamides, compositions containing them, and method of using them to inhibit gastric acid secretion
KR890002425B1 (ko) 1-(하이드록시페닐)-3-메틸-4-디플루오로메틸-△²-1,2,4-트리아졸린-5-온 유도체의 제조방법
JP2757353B2 (ja) インダン誘導体、その製法及びその合成中間体
EP0197664A2 (en) 2-Aminopyrimidinone derivatives
AT367049B (de) Verfahren zur herstellung von neuen pyrimidonderivaten
EP0193660A1 (en) 1-(Hydroxyphenyl)-3-methyl-4-difluoromethyl-(delta-2)-1,2,4-triazolin-5-one derivatives
JPS6212764A (ja) ジヒドロピリダジノン誘導体
CS241535B2 (cs) Způsob výroby derivátů guanidinu